Effect of radiotherapy and hyperthermia on the tumor accumulation of HPMA copolymer-based drug delivery systems

被引:107
作者
Lammers, Twan
Peschke, Peter
Kuehnlein, Rainer
Subr, Vladimir
Ulbrich, Karel
Debus, Juergen
Huber, Peter
Hennink, Wim
Storm, Gert
机构
[1] German Canc Res Ctr, Dept Innovat Canc Diag & Therapy, Clin Cooperat Unit Radiotherapeut Oncol, D-69120 Heidelberg, Germany
[2] Univ Utrecht, Dept Pharmaceut, Utrecht Inst Pharmaceut Sci, NL-3508 TB Utrecht, Netherlands
[3] Acad Sci Czech Republ, Inst Macromol Chem, CR-16206 Prague 6, Czech Republic
[4] Heidelberg Univ, Sch Med, Dept Radiat Oncol & Radiotherapy, D-69120 Heidelberg, Germany
关键词
HPMA; drug delivery systems; tumor targeting; radiotherapy; hyperthermia;
D O I
10.1016/j.jconrel.2006.10.032
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Copolymers of N-(2 -hydroxypropyl)methacrylamide (HPMA) are prototypic and we]]-characterized polymeric drug carriers that have been broadly implemented in the delivery of anticancer therapeutics. In an attempt to improve the tumor accumulation of HPMA copolymer-based drug delivery systems, their in vivo application was combined with radiotherapy and hyperthermia. As the effects of radiotherapy and hyperthermia were considered to depend significantly on the tumor model used, we first analyzed the accumulation of two differently sized HPMA copolymers in three different types of tumors, based on the syngeneic Dunning rat prostate carcinoma model. Subsequently, in these three models, the effects of different doses of radiotherapy and hyperthermia on the tumor accumulation of 31 kDa poly(HPMA), 65 kDa poly(HPMA) and 28 kDa poly (HPMA)-GFLG-doxorubicin were evaluated. It was found that the polymeric drug delivery systems accumulated effectively in all three tumor models. In addition, as opposed to hyperthermia, radiotherapy was found to improve the concentrations of the copolymers independent of the tumor model used. Based on these findings, we conclude that radiotherapy is an effective means for increasing the tumor accumulation of (polymeric) drug delivery systems, and we propose that the combination of carrier-based chemotherapy with radiotherapy holds significant potential for improving the treatment of advanced solid malignancies. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:333 / 341
页数:9
相关论文
共 62 条
[1]   Determinants of drug delivery and transport to solid tumors [J].
Au, JLS ;
Jang, SH ;
Zheng, J ;
Chen, CT ;
Song, S ;
Hu, L ;
Wientjes, MG .
JOURNAL OF CONTROLLED RELEASE, 2001, 74 (1-3) :31-46
[2]  
Bilim V, 2003, CURR OPIN MOL THER, V5, P326
[3]   Sublethal irradiation induces vascular endothelial growth factor and promotes growth of hepatoma cells: Implications for radiotherapy of hepatocellular carcinoma [J].
Chung, YL ;
Jian, JJM ;
Cheng, SHG ;
Tsai, SYC ;
Chuang, VP ;
Soong, T ;
Lin, YM ;
Horng, CF .
CLINICAL CANCER RESEARCH, 2006, 12 (09) :2706-2715
[4]  
COPE DA, 1990, CANCER RES, V50, P1803
[5]   Design of a multivalent galactoside ligand for selective targeting of HPMA copolymer-doxorubicin conjugates to human colon cancer cells [J].
David, A ;
Kopecková, P ;
Minko, T ;
Rubinstein, A ;
Kopecek, J .
EUROPEAN JOURNAL OF CANCER, 2004, 40 (01) :148-157
[6]   Radiation improves the distribution and uptake of liposomal doxorubicin (Caelyx) in human osteosarcoma xenografts [J].
Davies, CDL ;
Lundstrom, LM ;
Frengen, J ;
Eikenes, L ;
Bruland, OS ;
Kaahus, O ;
Hjelstuen, MHB ;
Brekken, C .
CANCER RESEARCH, 2004, 64 (02) :547-553
[7]   Identification of CD21-binding peptides with phage display and investigation of binding properties of HPMA copolymer-peptide conjugates [J].
Ding, H ;
Prodinger, WM ;
Kopecek, J .
BIOCONJUGATE CHEMISTRY, 2006, 17 (02) :514-523
[8]  
DUDAR TE, 1984, CANCER RES, V44, P605
[9]   The dawning era of polymer therapeutics [J].
Duncan, R .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (05) :347-360
[10]   TARGETING OF N-(2-HYDROXYPROPYL)METHACRYLAMIDE CO-POLYMERS TO LIVER BY INCORPORATION OF GALACTOSE RESIDUES [J].
DUNCAN, R ;
KOPECEK, J ;
REJMANOVA, P ;
LLOYD, JB .
BIOCHIMICA ET BIOPHYSICA ACTA, 1983, 755 (03) :518-521